1-{1-methyl-1H-pyrazolo[3,4-d]pyrimidin-4-yl}-4-(prop-2-yn-1-yl)piperazine

4-((4-((Methyl-4-((2-hydroxybutyl)oxy)phenyl)azo)phenyl)amino)-3-nitro-N-(phenylsulfonyl)benzenesulfonamide, lithium salt

Toxin I, entero-(Escherichia coli heat-stable reduced) 72

4-((4-((Methyl-4-((2-hydroxybutyl)oxy)phenyl)azo)phenyl)amino)-3-nitro-N-(phenylsulfonyl)benzenesulfonamide, sodium salt

benzene-1,4-diol;2-phenyl-1H-pyrazol-5-one;2-sulfanylacetic acid

l-Cysteine, S-((acetylamino)methyl)-N-(N-(N-(N-(N-(N2-(N-(N-(N-((1,1-dimethylethoxy)carbonyl)-l-phenylalanyl)-l-phenylalanyl)-l-tryptophyl)-N6-((2-(methylsulfonyl)ethoxy)carbonyl)-l-lysyl)-l-threonyl)-l-phenylalanyl)-l-threonyl)-l-seryl)-, 2-(((4-(phenylazo)phenyl)methyl)sulfonyl)ethyl ester

Somatostatin (sheep reduced), 1-de-l-alanine-2-deglycine-3-de-l-cysteine-4-(N2-((1,1-dimethylethoxy)carbonyl)-N6-((2-(methylsulfonyl)ethoxy)carbonyl)-l-lysine)-9-(N6-((2-(methylsulfonyl)ethoxy)carbonyl)-l-lysine)-14-(S-((acetylamino)methyl)-l-cysteine)-, 2-(((4-(phenylazo)phenyl)methyl)sulfonyl)ethyl ester

Somatostatin (sheep reduced), 1-de-l-alanine-2-deglycine-3-(S-((acetylamino)methyl)-N-((1,1-dimethylethoxy)carbonyl)-l-cysteine)-4-(N6-((2-(methylsulfonyl)ethoxy)carbonyl)-l-lysine)-9-(N6-((2-(methylsulfonyl)ethoxy)carbonyl)-l-lysine)-14-(S-((acetylamino)methyl)-l-cysteine)-, 2-(((4-(phenylazo)phenyl)methyl)sulfonyl)ethyl ester

2-Aminoethanol;chromium;hydron;1-[(2-hydroxy-4-nitrophenyl)diazenyl]naphthalen-2-ol;2-[[3-methyl-5-oxo-1-(4-sulfophenyl)pyrazol-4-id-4-yl]diazenyl]benzoic acid

Toxin, entero-(Escherichia coli strain 18D heat-stable reduced) 18

Trisodium (5-((4,5-dihydro-3-methyl-5-oxo-1-phenyl-1H-pyrazol-4-yl)azo)-4-hydroxy-3-((2-hydroxy-3-nitro-5-sulphophenyl)azo)naphthalene-2,7-disulphonato(5-))nickelate(3-)